109 related articles for article (PubMed ID: 20063376)
1. Identification of circulating placental mRNA in maternal blood of pregnancies affected with fetal congenital heart diseases at the second trimester of pregnancy: implications for early molecular screening.
Arcelli D; Farina A; Cappuzzello C; Bresin A; De Sanctis P; Perolo A; Prandstraller D; Valentini D; Zucchini C; Priori S; Rizzo N
Prenat Diagn; 2010 Mar; 30(3):229-34. PubMed ID: 20063376
[TBL] [Abstract][Full Text] [Related]
2. A microarray approach for systematic identification of placental-derived RNA markers in maternal plasma.
Tsui NB; Lo YM
Methods Mol Biol; 2008; 444():275-89. PubMed ID: 18425489
[TBL] [Abstract][Full Text] [Related]
3. Quantitative distribution of a panel of circulating mRNA in preeclampsia versus controls.
Farina A; Sekizawa A; Purwosunu Y; Rizzo N; Banzola I; Concu M; Morano D; Giommi F; Bevini M; Mabrook M; Carinci P; Okai T
Prenat Diagn; 2006 Dec; 26(12):1115-20. PubMed ID: 16952198
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of combining maternal serum alpha-fetoprotein and hCG in a second-trimester screening program for Down syndrome.
Mooney RA; Peterson CJ; French CA; Saller DN; Arvan DA
Obstet Gynecol; 1994 Aug; 84(2):298-303. PubMed ID: 7518896
[TBL] [Abstract][Full Text] [Related]
5. Human chorionic gonadotropin and plasma protein-A in alpha0-thalassemia pregnancies.
Ong CY; Lee CP; Leung KY; Lau E; Tang MH
Obstet Gynecol; 2006 Sep; 108(3 Pt 1):651-5. PubMed ID: 16946227
[TBL] [Abstract][Full Text] [Related]
6. mRNA of placental origin is readily detectable in maternal plasma.
Ng EK; Tsui NB; Lau TK; Leung TN; Chiu RW; Panesar NS; Lit LC; Chan KW; Lo YM
Proc Natl Acad Sci U S A; 2003 Apr; 100(8):4748-53. PubMed ID: 12644709
[TBL] [Abstract][Full Text] [Related]
7. Small scale transcript expression profile of Human first trimester placental villi analyzed by a custom-tailored cDNA array.
Khan MA; Kar M; Mittal S; Kumar S; Bharagava VL; Sengupta J; Ghoshi D
Indian J Physiol Pharmacol; 2010; 54(3):235-54. PubMed ID: 21409862
[TBL] [Abstract][Full Text] [Related]
8. Identification of second trimester screen positive pregnancies at increased risk for congenital heart defects.
Jelliffe-Pawlowski LL; Walton-Haynes L; Currier RJ
Prenat Diagn; 2009 Jun; 29(6):570-7. PubMed ID: 19266536
[TBL] [Abstract][Full Text] [Related]
9. Genetic expression by fetal chorionic villi during the first trimester of human gestation.
Dizon-Townson DS; Lu J; Morgan TK; Ward KJ
Am J Obstet Gynecol; 2000 Sep; 183(3):706-11. PubMed ID: 10992197
[TBL] [Abstract][Full Text] [Related]
10. PLAC1 mRNA in maternal blood correlates with Doppler waveform in uterine arteries in normal pregnancies at the second and third trimester.
Farina A; Concu M; Banzola I; Tempesta A; Vagnoni S; Gabrielli S; Mattioli M; Carinci P; Pilu G; Morano D; Rizzo N
Ann N Y Acad Sci; 2006 Sep; 1075():130-6. PubMed ID: 17108202
[TBL] [Abstract][Full Text] [Related]
11. Insulin-like growth factors I and II peptide and messenger RNA levels in macrosomic infants of diabetic pregnancies.
Roth S; Abernathy MP; Lee WH; Pratt L; Denne S; Golichowski A; Pescovitz OH
J Soc Gynecol Investig; 1996; 3(2):78-84. PubMed ID: 8796812
[TBL] [Abstract][Full Text] [Related]
12. Predicting the result of additional second-trimester markers from a woman's first-trimester marker profile: a new concept in Down syndrome screening.
Maymon R; Cuckle H; Jones R; Reish O; Sharony R; Herman A
Prenat Diagn; 2005 Dec; 25(12):1102-6. PubMed ID: 16231324
[TBL] [Abstract][Full Text] [Related]
13. Placental mosaicism is associated with unexplained second-trimester elevation of MShCG levels, but not with elevation of MSAFP levels.
Morssink LP; Sikkema-Raddatz B; Beekhuis JR; De Wolf BT; Mantingh A
Prenat Diagn; 1996 Sep; 16(9):845-51. PubMed ID: 8905899
[TBL] [Abstract][Full Text] [Related]
14. Are Down syndrome fetuses detected through maternal serum screening similar to those remaining undetected?
Christiaens GC; Hagenaars AM; Akkerman C; De France HF
Prenat Diagn; 1996 May; 16(5):437-42. PubMed ID: 8844002
[TBL] [Abstract][Full Text] [Related]
15. B7 family molecules are favorably positioned at the human maternal-fetal interface.
Petroff MG; Chen L; Phillips TA; Azzola D; Sedlmayr P; Hunt JS
Biol Reprod; 2003 May; 68(5):1496-504. PubMed ID: 12606489
[TBL] [Abstract][Full Text] [Related]
16. A prospective analysis of cell-free fetal DNA concentration in maternal plasma as an indicator for adverse pregnancy outcome.
Bauer M; Hutterer G; Eder M; Majer S; Leshane E; Johnson KL; Peter I; Bianchi DW; Pertl B
Prenat Diagn; 2006 Sep; 26(9):831-6. PubMed ID: 16832830
[TBL] [Abstract][Full Text] [Related]
17. Multicenter study of first-trimester screening for trisomy 21 in 75 821 pregnancies: results and estimation of the potential impact of individual risk-orientated two-stage first-trimester screening.
Nicolaides KH; Spencer K; Avgidou K; Faiola S; Falcon O
Ultrasound Obstet Gynecol; 2005 Mar; 25(3):221-6. PubMed ID: 15736186
[TBL] [Abstract][Full Text] [Related]
18. mRNA of placental origin in maternal serum of women with normal and preeclamptic pregnancies.
Schmidt M; Hoffmann B; Kimmig R; Kasimir-Bauer S
Fetal Diagn Ther; 2009; 25(2):269-76. PubMed ID: 19521094
[TBL] [Abstract][Full Text] [Related]
19. Significant correlation between maternal body mass index at delivery and in the second trimester, and second trimester circulating total cell-free DNA levels.
Lapaire O; Volgmann T; Grill S; Hösli I; Zanetti-Daellenbach R; Zhong XY; Holzgreve W
Reprod Sci; 2009 Mar; 16(3):274-9. PubMed ID: 19087977
[TBL] [Abstract][Full Text] [Related]
20. [Prenatal screening for major fetal defects by using of maternal serum markers].
Bao P; Wu Y; Gu Q
Zhonghua Fu Chan Ke Za Zhi; 1997 Nov; 32(11):649-51. PubMed ID: 9639762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
